- Rare disease biotech Beren adds $300M from new financingsAnxiously awaiting an FDA decision this fall, Beren Therapeutics has added $300 million in new capital to help launch its rare disease drug. The biotech announced Wednesday that it raised $135 ...Endpoints · 1mo ago↗ source
- Parabilis CEO Mathai Mammen on biotech's record IPOParabilis Medicines cemented the largest biotech IPO in industry history on Wednesday with its $670 million debut on the Nasdaq. But the Cambridge, MA-based drug developer won't be celebrating at t…Endpoints · 1mo ago↗ source
- STAT+: Your sepsis algorithm shouldn’t require a time machineIn this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.STAT · 1mo ago